黑料官网

header-logo
GettyImages-609179959-hero
headshot

Paul Hanna, MD, MSc

Director of Onconephrology, Assistant Professor

view physician profile

Locations

  • Froedtert Hospital
  • Nephrology - Center for Advanced Care - Froedtert Hospital

Specialties

  • Nephrology

Languages

  • English, Arabic

Established Patient Appointments

New Patient Appointments

Education

  • MD - Doctor of Medicine
  • MSc - Master of Science

Clinical Expertise

  • Acute Kidney Injury
  • Atypical Hemolytic Uremic Syndrome
  • Chronic Kidney Disease-Mineral and Bone Disorder
  • Essential Hypertension
  • Glomerulonephritis
  • Hydronephrosis
  • Hyperparathyroidism, Secondary
  • Hypertension
  • Hypertension, Renal
  • Hypertension, Renovascular
  • Kidney Diseases
  • Kidney Failure, Chronic

Publications

  • (Moreno D, Hanna PE, Mistry K, Heidari P, Sise ME, Seethapathy H.) Kidney Med. 2025 Aug;7(8):101038 PMID: 40740732 PMCID: PMC12304893 07/31/2025

  • (Lyu J, Mantz L, Katz-Agranov NS, Ouyang T, Hanna PE, Mejia SM, Moreno D, Lee M, Cao A, Dinulos JE, Cosar D, Shaker M, Shah SJ, Gainor JF, Temel JS, Lei M, Inker LA, Fintelmann FJ, Sise ME.) J Natl Compr Canc Netw. 2025 Jul 30;23(9):393-400 PMID: 40738140 SCOPUS ID: 2-s2.0-105015792212 07/31/2025

  • (Lyu J, Specht K, Seiglie JA, Ouyang T, Mistry K, Seethapathy H, Zubiri L, Khor SY, Hanna PE, Cao A, Moreno D, Mejia SM, Gupta S, Sise ME.) Cancer Lett. 2025 Jul 28;632:217958 PMID: 40738413 07/31/2025

  • (Sarmad A, Ghozloujeh ZG, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, Mathew R, Ahmad M, Mohammed A, Siddiqui S, Abdipour A, Norouzi S.) Nephrol Dial Transplant. 2025 Apr 25 PMID: 40280728 04/26/2025

  • (Vakhshoori M, Hanna PE, Obaidi Z, Chen Wongworawat Y, Abdipour A, Norouzi S.) J Investig Med High Impact Case Rep. 2025;13:23247096251323066 PMID: 40069965 PMCID: PMC11898078 03/12/2025

  • (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney Int Rep. 2024 Jun;9(6):1897-1902 PMID: 38899179 PMCID: PMC11184235 06/20/2024

  • (Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, Strohbehn I, Moreno D, Harden D, Dinulos JE, Cosar D, Seethapathy H, Gainor JF, Shah SJ, Gupta S, Leaf DE, Fintelmann FJ, Sise ME.) J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1187-1198 PMID: 38646842 PMCID: PMC11154767 SCOPUS ID: 2-s2.0-85191144047 04/22/2024

  • (Mistry K, Zhao S, Strohbehn I, Wang Q, Hanna P, Strohbehn S, Katz-Agranov N, Sullivan RJ, Sise ME.) Nephrol Dial Transplant. 2024 May 31;39(6):1040-1043 PMID: 38389257 SCOPUS ID: 2-s2.0-85194906171 02/23/2024

  • (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney International Reports. June 2024;9(6):1897-1902 SCOPUS ID: 2-s2.0-85189238641 06/01/2024

  • (Wang Q, Seethapathy R, Ouyang T, Strohbehn IA, Katz-Agranov N, Hanna P, Madken M, Seethapathy H, Gupta S, Heller HM, Wszolek M, Steele D, Klepeis VE, Rennke H, Sise ME.) Kidney International Reports. December 2023;8(12):2833-2837 SCOPUS ID: 2-s2.0-85173386703 12/01/2023

  • (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney International Reports. doi: 10.1016/j.ekir.2024.03.005 03/13/2024

  • (Mistry K, Zhao S, Strohbehn I, Wang Q, Hanna P, Strohbehn S, Katz-Agranov N, Sullivan RJ, Sise M.) Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfae049 02/22/2024

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.